The vast majority of research and development efforts, and consequently the approved products, within the malaria vaccine space are focused on the Plasmodium falciparum agent. This specific parasite species is responsible for the most severe forms of the disease and accounts for the overwhelming majority of malaria-related deaths globally, particularly in Africa. This high fatality rate makes...
The robust growth trajectory of the malaria vaccine segment is heavily reliant on the escalating flow of global investment and collaborative funding from public-private partnerships. Major international organizations, government agencies, and philanthropic bodies like the WHO, Gavi, and the Bill & Melinda Gates Foundation are significantly increasing their financial commitments to malaria...